The Middletown Project was undertaken as a combined trial and demonstration of how the Sabin oral poliovirus vaccine could be given on a city-wide, simultaneous or mass basis in an urban American community of approximately 30,000 population. Specific objectives were multiple. They included: the assessment of the immunological effectiveness of this immunizing agent when given in such a setting; a determination of the degree of public acceptance of the vaccine; a delineation of the respective roles in a community vaccination campaign of a research group such as the Yale University Poliomyelitis Study Unit, the City Health officer, and the practicing physicians; and an analysis of the actual problems or mechanics of vaccine administration.
This was an ambitious project for a research group of the size of the Yale Poliomyelitis Study Unit, and, as mentioned in the preceding paper, it was far and away the largest vaccine trial as yet attempted by this group. Without the participation of graduate students from the Department of Epidemiology and Public Health (Yale University) and of many more members of the faculty than had been recruited for such studies before, and without the vigorous participation of the Middletown Department of Health and its director, a study of this magnitude could never have been accomplished. Indeed one might question the advisability of a university research group initiating a project calling for mass vaccination of an urban population on such a scale. A university group is better equipped to carry out small and detailed trials in which exacting studies are made, such as, for instance, the trial involving approximately 200 New Haven families which this Study Unit completed in early 1960. 1 However, in 1961 1 However, in -1962 , during the early stages of official licensing of the oral poliovirus vaccine, there is also a need for more precise information and knowledge regarding the community-wide use of this new form of vaccine and, in view of our previous experience, the present project has proved to be a suitable one for our Study Group.
To engage in a city-wide trial in an urban population of 30,000 or more is a task which calls for a considerable degree of planning. The extent to which state or municipal departments of health are able to devote time, personnel, and other facilities for such an undertaking must be decided well in advance; the time, interest, and support which the practicing physicians can afford to give deserves careful thought and discussion in the local medical societies. For this reason we have gone into some detail in describing how this project, sponsored jointly by a university and by a municipal health department, has been implemented.
It will be unfortunate indeed if when the use of oral poliovirus vaccine becomes official in the United States, advantage is not taken of the opportunity to explore new approaches in order to achieve more complete coverage of the population than has been the case with the Salk-type vaccine.2 The nature of the oral vaccine which allows ingestion to replace injection makes it ideally suited to rapid and painless administration to large segments of the population. In planning the Middletown project, a major aim was to achieve at least an 85 per cent level of immunization in both the school-age population and in the preschool children between three months and five years of age. A special effort was made to cover the hard-to-reach groups, particularly those of low socio-economic levels.
MIDDLETOWN, CONNECTICUT
The city and its people. The city of Middletown (of which illustrations are shown in Figs. 1 and 2 , and a map in Fig. 3 These were well outlined in advance and required little modification as the trial progressed. In essence the objectives were:
i. To determine what per cent of the designated age groups of the population could be reached with oral vaccine offered in sequential doses to all children aged 3 months to 18 years in the urban, suburban, and semi-rural area of Middletown, Connecticut.
ii. To conduct studies on factors influencing acceptance or rejection of oral vaccine by different socio-economic groups. This would include a retrospective assay of attitudes towards the Salk-type vaccine.
iii. To make special efforts to reach the preschool group, utilizing all available local mechanisms for determining its size in advance, so that as wide a coverage as possible of children of this most susceptible age could be achieved.
iv. To assay the attitudes of the local medical profession toward the program and the degree to which physicians were willing to participate. vi. To conduct pre-vaccinal and post-vaccinal serological studies in order to determine the immunizing capacity of the oral vaccine, given in two sequential doses, six weeks apart, to this particular population.* *An original plan to administer the vaccine in three separate doses of monovalent vaccine was changed to a program in which the vaccine was given in two doses: a first dose of monovalent type I vaccine, and six weeks later a second dose of bivalent vaccine, types II and III. The decision to adopt the new schedule was based largely on the successful result with this regimen obtained by our Study Unit in the New Haven City oral poliovirus vaccine trial carried out in 1960 among preschool children.' vii. To conduct virological surveys prior to, during, and after the trial. These studies were to be aimed in part toward the determination of prevalence of enteroviruses which might act as interfering agents, and in part toward determining the persistence of the attenuated polioviruses in the community. Sampling of the sewage on a weekly basis before and after the trial and periodic collection of rectal swabs from young children attending the well-child clinic were the survey methods chosen for this purpose. vaccination program should be the responsibility of the health officer and project directors. They favored the setting up of clinics in schools or other appropriate locations where the vaccine could be given under medical supervision, both to school and preschool children.* It was agreed that the name of the private physician would be written on the permission slip, and subsequently, information as to the actual date on which the first and second doses of vaccine were received would be recorded and sent to the child's physician after the vaccination program had been completed. Finally, when the immunization results in terms of antibody responses were available, these would also be sent to the physicians concerned.
As a major premise from the beginning, it was assumed that the oral vaccine would be given under medical superzision. 
